Cancer

A new study by WSU researchers suggests that a protein called CDK2 plays a critical role in heart damage caused by doxorubicin, a commonly used chemotherapy drug.

Identifying cancer and other health biomarkers in real-time is the aim of a software development project.

A promising but little-used type of cancer treatment has been markedly improved by introducing the use of tiny particles of gold and platinum.

By Eric Sorensen, WSU News SPOKANE, Wash. – For the first time, WSU researchers have demonstrated a way to deliver a drug to a tumor by attaching it to a blood cell. The innovation could let doctors target tumors with anticancer drugs that might otherwise damage healthy tissues.

By Eric Sorensen, WSU science writer PULLMAN, Wash. – Washington State University researchers have found a promising way to preserve sperm stem cells so boys could undergo cancer treatment without risking their fertility.

By Will Ferguson, College of Arts & Sciences PULLMAN, Wash. – Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease’s progression.

By Eric Sorensen, WSU science writer SPOKANE, Wash. – A Washington State University researcher has found a way that prostate cancer cells hijack the body’s bone maintenance, facilitating the spread of bone cancers present in some 90 percent of prostate-cancer fatalities.

By Seth Truscott, College of Agricultural, Human & Natural Resource Sciences PULLMAN, Wash. – A natural defense that helps plants ward off insect predators, discovered at Washington State University, could lead to better crops and new treatments for cancer and Alzheimer’s disease.

By Eric Sorensen, WSU science writer PULLMAN, Wash. – A Washington State University researcher has documented epigenetic changes in the sperm of men who underwent chemotherapy in their teens.

PULLMAN, Wash. – Biochemist James A. Wells, a pioneering engineer of proteins, antibodies and small molecules that target cell sites to thwart disease and enhance drug therapies, will receive the Regents’ Distinguished Alumnus Award at 3:45 p.m. Wednesday, Jan. 25, in the CUB auditorium at Washington State University.